Is the US prepared to deal with another pandemic or widespread health crisis?
No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful progress in some technical and institutional areas since COVID-19. Significant gaps remain in funding sustainability, implementation of lessons learned, workforce capacity, supply chains, state-level readiness, coordination, and political will, leaving the country vulnerable.[1]
Progress Since COVID-19
The Biden-Harris administration and agencies took steps informed by COVID lessons, including:
These build on existing frameworks like the Pandemic and All-Hazards Preparedness Act (PAHPA) and Strategic National Stockpile (SNS). The US retains strong scientific and manufacturing potential.
Persistent Gaps and Criticisms
Independent assessments highlight incomplete readiness:
Ongoing responses to H5N1 (in cattle/poultry, limited human cases mostly mild but with fatalities) and mpox show improved tools but highlight detection, coordination (human-animal interface), and rapid scaling challenges.[4]
Broader Context and Outlook
Preparedness is not binary—it involves prevention, detection, response, and recovery across federal, state, local, private, and global levels. The US has elite capabilities in biotech and some surveillance but weaker sustained public health infrastructure, equity, hospital surge capacity relative to peers in some metrics, and consistent multi-year funding/political prioritization. Historical underinvestment and politicization undermine resilience.[10]
A major novel pathogen (or engineered threat) could still overwhelm systems, especially early on, due to testing/PPE/supply lags, workforce limits, misinformation, and coordination frictions—mirroring COVID shortfalls despite improvements. Experts emphasize that “preparedness works” when sustained, and action (funding, implementation of GAO/Blueprint recommendations, PAHPA strengthening, equity focus, domestic manufacturing, better vaccines/therapeutics platforms) could close gaps. Without it, vulnerability persists.[1]
In short, the US is better equipped in targeted technical areas than in 2019 but falls short of robust, resilient readiness for a severe widespread crisis. Continued bipartisan investment and execution will determine the trajectory.
Citations (10)
- https://www.bmj.com/content/384/bmj.q332
Backs: “Significant gaps remain in funding sustainability, implementation of lessons learned, workforce capacity, supply chains, state-level readiness, coordination, and political will, leaving the country vulnerable.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Establishing the permanent White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023 to coordinate biothreat efforts.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: “Expanded wastewater monitoring (National Wastewater Surveillance System), traveler-based genomic surveillance (which detected Omicron variants early), electronic case reporting (from ~187 facilities pre-pandemic to over 45,000+ by late 2024), and syndromic data from most hospital EDs.”
- https://www.presidency.ucsb.edu/documents/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response
Backs: “A National Biodefense Strategy aims for 100-day vaccine development capabilities.”
- https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report
Backs: “Global health security investments (over $3 billion since 2020) and strategies to strengthen partner countries’ capacities.”
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “It calls for immediate action on leadership, intelligence/deterrence, science/tech, preparedness, detection/surveillance, and response/recovery, noting biological threats are growing (natural, accidental, deliberate). Fractionated efforts and boom-bust cycles persist.”
- https://www.gao.gov/products/gao-24-107175
Backs: “Lessons cover planning, contracting, testing, equity, and recovery.”
- https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/
Backs: “SNS has been replenished in places but faces broader medical countermeasure and manufacturing challenges. PAHPA reauthorization is key but faces debates.”
- https://www.tfah.org/report-details/ready-or-not-2025-protecting-the-publics-health-from-diseases-disasters-and-bioterrorism/
Backs: “Many are middle or low tier, with risks from funding cuts, staffing instability, and rising outbreaks (severe flu, measles, ongoing H5N1).”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Historical underinvestment and politicization undermine resilience.”